A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä
Transformation and causes of death in follicular lymphoma: A Finnish nationwide population‐based study
Tekijät: Kalashnikov, Ilja; Reunamo, Taina; Tanskanen, Tomas; Viisanen, Leevi; Malila, Nea; Jyrkkiö, Sirkku; Leppä, Sirpa
Kustantaja: Wiley-Blackwell
Julkaisuvuosi: 2025
Lehti: British Journal of Haematology
Artikkelin numero: bjh.70181
ISSN: 0007-1048
eISSN: 1365-2141
DOI: https://doi.org/10.1111/bjh.70181
Julkaisun avoimuus kirjaamishetkellä: Avoimesti saatavilla
Julkaisukanavan avoimuus : Osittain avoin julkaisukanava
Verkko-osoite: https://doi.org/10.1111/bjh.70181
Rinnakkaistallenteen osoite: https://research.utu.fi/converis/portal/detail/Publication/504556157
Follicular lymphoma (FL) is a common, indolent lymphoma, and patients with FL typically have a good prognosis. However, they may experience histological transformation into aggressive large B-cell lymphoma. We conducted a nationwide population-based study to estimate the risk of transformation in FL, considering different FL grades, and studied the relative survival (RS) of patients diagnosed with FL in Finland from 1995 to 2018. We identified a total of 4014 patients with newly diagnosed grade 1–3A FL. The median age at diagnosis was 64 years, and 55% of patients were female. The cumulative incidence of transformation across the entire cohort was 8.4% at 10 years (95% confidence interval [CI], 7.5–9.5). The 10-year RS was 78% for the whole cohort and showed improvement over time. Transformation was associated with a significantly increased risk of death (hazard ratio [HR] 5.0; 95% CI, 4.2–6.0; p < 0.001). Grade 3A was associated with higher excess mortality compared to patients with low-grade FL. Lymphoma was the most common cause of death. We conclude that, although the 10-year RS was relatively good, grade 3A FL and transformation led to significantly higher mortality compared to low-grade FL or no transformation. Our results also indicate a reduction in excess mortality over time.
Ladattava julkaisu This is an electronic reprint of the original article. |
Julkaisussa olevat rahoitustiedot:
This research was funded by grants from the Academy of Finland (SL), Finnish Cancer Organizations (SL), Sigrid Juselius Foundation (SL), University of Helsinki (SL), Helsinki University Hospital (SL), Finnish Society for Oncology (IK and TR) and Turku University Hospital (TR). Open access publishing facilitated by Helsingin yliopisto, as part of the Wiley - FinELib agreement.